上海莼试生物技术有限公司
   
菜单 Close 公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 产品展厅 >抗体 >重组激活基因2蛋白抗体品牌
产品展厅
重组激活基因2蛋白抗体品牌
  • 品牌:上海莼试
  • 产地:进口、国产
  • 货号:CS11031
  • 发布日期: 2019-01-07
  • 更新日期: 2024-11-27
产品详请
产地 进口、国产
品牌 上海莼试
保存条件 Store at -20 °C
货号 CS11031
应用范围 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS编号
抗体名 Anti-RAG2
克隆性
靶点 详见说明书
适应物种 详见说明书
形态 详见说明书
宿主 详见说明书
亚型 IgG
标识物 详见说明书
浓度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human RMND1

中文名称  重组激活基因2蛋白抗体品牌 

英文名称  Anti-RAG2

     RAG 2; RAG-2; RAG2; RAG2_HUMAN; Recombination activating gene 2; V(D)J recombination activating protein 2; V(D)J recombination-activating protein 2.

产品属性:

重组激活基因2蛋白抗体品牌       1mg/1ml

  0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep

产品类型   一抗  

研究领域    细胞生物 免疫学 表观遗传学

蛋白分子量  predicted molecular weight: 58kDa 

       Lyophilized or Liquid

  KLH conjugated synthetic peptide derived from human RAG2

      IgG

纯化方法   affinity purified by Protein A

   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

重组激活基因2蛋白抗体品牌 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蜡切片需做抗原修复) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In addition to its endonuclease activity, RAG1 also acts as a E3 ubiquitin-protein ligase that mediates monoubiquitination of histone H3. Histone H3 monoubiquitination is required for the joining step of V(D)J recombination. Mediates polyubiquitination of KPNA1.

Function : Core component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. DNA cleavage by the RAG complex occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In the RAG complex, RAG2 is not the catalytic component but is required for all known catalytic activities mediated by RAG1. It probably acts as a sensor of chromatin state that recruits the RAG complex to H3K4me3.

Subunit : Component of the RAG complex composed of core components RAG1 and RAG2, and associated component HMGB1 or HMGB2.

Subcellular Location : Nucleus.

DISEASE : Defects in RAG2 are a cause of combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]. CHIDG is an immunodeficiency disease with granulomas in the skin, mucous membranes, and internal organs. Other characteristics include hypogammaglobulinemia, a diminished number of T and B-cells, and sparse thymic tissue on ultrasonography.

Defects in RAG2 are a cause of severe combined

immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.

Defects in RAG2 are a cause of Omenn syndrome (OS) [MIM:603554]. OS is a severe immunodeficiency characterized by the presence of activated, anergic, oligoclonal T-cells, hypereosinophilia, and high IgE levels.

Similarity : Belongs to the RAG2 family.

Contains 1 PHD-type zinc finger.

Database links : UniProtKB/Swiss-Prot: P55895.1

实验流程:

全、新、优、品、好四大特点:

重组激活基因2蛋白抗体品牌 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。

新:产品更新速度较快,基本上每周都有新产品出现。

优:产品质量好,投诉比较少。

好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

重组激活基因2蛋白抗体品牌 分子生物学:质粒抽提、PCRQ-PCRRT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等

蛋白工程:原核、哺乳动物蛋白表达系统等

病毒包装:腺病毒、慢病毒等

抗体工程:磁珠分选、病理染色、WBELISAIPIFIHCFACSConfocal等等

细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品:

MAPK4(Mitogen-activated protein kinase 4) 原活化蛋白激酶4抗原Multi-class antibodies规格: 0.5mg

轴蛋白1Axin protein 1抗体 Anti-Axin1 0.1ml

Rhesus antibody Rh phospho-EGFR (Tyr1068) 磷酸化表皮生长因子受体抗体 规格 0.1ml

B27添加剂 (原装) 10ml Gibco

ZNF750 英文名称: 锌指蛋白750抗体 0.2ml

DTNBP1 英文名称: 易感基因抗体 0.1ml

轴蛋白1Axin protein 1抗体 Anti-Axin1 0.1ml

EphA1 R(Ephrin A1 Receptor) EphA1-R受体抗原Multi-class antibodies规格: 0.5mg

ATP酶通道蛋白抗体 Anti-ATP1b2/Na+K+ ATPase 0.1ml

Rhesus antibody Rh Phospho-EGFR (Tyr1138) 磷酸化表皮生长因子受体抗体 规格 0.1ml

DMEM/F12(1:1)培养液 250ml 国产

ZNF672 英文名称: 锌指蛋白672抗体 0.2ml

DISC1 (CT) 英文名称: DISC1 C端抗体 0.2ml

ATP酶通道蛋白抗体 Anti-ATP1b2/Na+K+ ATPase 0.1ml

ZEB1 英文名称: 负调控因子白细胞介素2抗体 0.2ml

DR1 protein 英文名称: 转录下调蛋白1抗体 0.2ml

衔接因子蛋白含pH域磷酸酪氨酸结合域和亮氨酸拉链基元1抗体 Anti-APPL1 0.1ml

Anti-CEA/Gold 胶体金离子标记鼠抗人癌胚抗原单克隆抗体(包被)IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh Phospho-eNOS (Thr113) 磷酸化合成酶3抗体(内皮型) 规格 0.1ml

E2F2 转录因子E2F-2抗原Multi-class antibodies规格: 0.5mg

TNFSF12 Protein Rat 重组大鼠 TNFSF12 蛋白 (Fc 标签)

DLD-1 人结直肠腺癌上皮细胞

CTSD Others Human 人 Cathepsin D / CTSD 人细胞裂解液 (阳性对照)

CMVECs微内皮细胞 CMVECs micro vascular endothelial cells DMEM+10%FBS

人导管癌细胞;ZR-75-1

人小梁网细胞(HTMC)(5×105) 3T3-L1, 小鼠前脂肪细胞 Mouse

CL-0435SF126(人细胞)5×106cells/瓶×2

HA Others H12N1 甲型 H12N1 (A/mallard duck/Alberta/342/1983) 血凝素 (Hemagglutinin / HA) 人细胞裂解液 (阳性对照)

大鼠视网膜神经节细胞完全培养基 100mL

HL-7702人正常肝细胞 HL-7702 human normal liver cell 1640+10% FBS

IL1RN Protein Rat 重组大鼠 IL-1RA / IL1RN 蛋白 (Fc 标签)

NCI-H596(人肺腺鳞癌细胞) 5×106cells/瓶×2 cv-1(非洲绿猴肾细胞)

重组激活基因2蛋白抗体品牌 TNFSF12 Protein Rat 重组大鼠 TNFSF12 蛋白 (Fc 标签)

DLD-1 人结直肠腺癌上皮细胞

CTSD Others Human Cathepsin D / CTSD 人细胞裂解液 (阳性对照)

CMVECs微内皮细胞 CMVECs micro vascular endothelial cells DMEM+10%FBS

人导管癌细胞;ZR-75-1

人小梁网细胞(HTMC)(5×105) 3T3-L1, 小鼠前脂肪细胞 Mouse


联系方式
手机:13585831301
Q Q: